Broadcom
AVGO
Salesforce
CRM
Micron Technology
MU
4
Qualcomm
QCOM
5
Oracle
ORCL
iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984. The company was founded by Michel Detheux in April 2012 and is headquartered in Watertown, MA.